After-Hours Stock Movers 03/17: (UPST) (WSM) (FIVE) Higher; (TBIO) (CFRX) (SLDB) Lower (more...)

March 17, 2021 5:40 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

After-Hours Stock Movers:

Upstart Holdings. (NASDAQ: UPST) 46% HIGHER; reported Q4 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $86.7 million versus the consensus estimate of $74.06 million. Upstream Worldwide, Inc. sees Q1 2021 revenue of $112-118 million, versus the consensus of $73.78 million. Upstream Worldwide, Inc. sees FY2021 revenue of $500 million, versus the consensus of $354.3 million.

Translate Bio (Nasdaq: TBIO) 14.5% LOWER; announced results from the second interim analysis from a first-in-human Phase 1/2 clinical trial evaluating the safety and tolerability of single- and multiple-ascending doses of MRT5005 in patients with cystic fibrosis (CF). MRT5005 is designed to address the underlying cause of CF regardless of genetic mutation by delivering mRNA encoding fully functional cystic fibrosis transmembrane conductance regulator (CFTR) protein to cells in the lung through nebulization.

ContraFect Corporation (Nasdaq: CFRX) 13.3% LOWER; announced that it has commenced an underwritten public offering of shares of its common stock.

Williams-Sonoma (NYSE: WSM) 11.5% HIGHER; reported Q4 EPS of $3.95, $0.56 better than the analyst estimate of $3.39. Revenue for the quarter came in at $2.29 billion versus the consensus estimate of $2.17 billion.

Five Below (NASDAQ: FIVE) 5.5% HIGHER; reported Q4 EPS of $2.20, $0.09 better than the analyst estimate of $2.11. Revenue for the quarter came in at $858.5 million versus the consensus estimate of $838.26 million. Five Below sees Q1 2021 EPS of $0.56-$0.68, versus the consensus of $0.39. Five Below sees Q1 2021 revenue of $540-560 million, versus the consensus of $440.91 million.

Solid Biosciences Inc., (Nasdaq: SLDB) 4.8% LOWER; announced that it has commenced an underwritten public offering of $85 million of shares of its common stock.

PagerDuty, Inc. (NYSE: PD) 4.8% LOWER; reported Q4 EPS of ($0.07), $0.04 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $59.3 million versus the consensus estimate of $57.47 million. PagerDuty, Inc. sees Q1 2022 EPS of ($0.10)-($0.09), versus the consensus of ($0.07). PagerDuty, Inc. sees Q1 2022 revenue of $61-63 million, versus the consensus of $60.96 million. PagerDuty, Inc. sees FY2022 EPS of ($0.43)-($0.36), versus the consensus of ($0.21). PagerDuty, Inc. sees FY2022 revenue of $264-270 million, versus the consensus of $262.63 million.

22nd Century Group (NYSE: XXII) 4.5% HIGHER; Director, Roger O'Brien, bought 52,400 shares on 03/16 at $2.86.

Herman Miller (NASDAQ: MLHR) 3% LOWER; reported Q3 EPS of $0.65, $0.07 better than the analyst estimate of $0.58. Revenue for the quarter came in at $590.5 million versus the consensus estimate of $587.27 million.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

After-Hours Movers